AAAAAA
Results:
1-14
|
Results: 14
Authors:
Koo, SP
Bayer, AS
Yeaman, MR
Citation: Sp. Koo et al., Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides, INFEC IMMUN, 69(8), 2001, pp. 4916-4922
Authors:
Dhawan, VK
Bayer, AS
Yeaman, MR
Citation: Vk. Dhawan et al., Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis, ANTIM AG CH, 44(11), 2000, pp. 3206-3209
Authors:
Xiong, YQ
Yeaman, MR
Bayer, AS
Citation: Yq. Xiong et al., Linezolid: A new antibiotic, DRUGS TODAY, 36(9), 2000, pp. 631-639
Authors:
Xiong, YQ
Yeaman, MR
Bayer, AS
Citation: Yq. Xiong et al., New approaches to the prevention and treatment of severe S-aureus infections, DRUGS TODAY, 36(8), 2000, pp. 529-539
Authors:
Fowler, VG
McIntyre, LM
Yeaman, MR
Peterson, GE
Reller, LB
Corey, GR
Wray, D
Bayer, AS
Citation: Vg. Fowler et al., In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates withan intravascular device source, J INFEC DIS, 182(4), 2000, pp. 1251-1254
Authors:
Mercier, RC
Rybak, MJ
Bayer, AS
Yeaman, MR
Citation: Rc. Mercier et al., Influence of platelets and platelet microbicidal protein susceptibility onthe fate of Staphylococcus aureus in an in vitro model of infective endocarditis, INFEC IMMUN, 68(8), 2000, pp. 4699-4705
Authors:
Bayer, AS
Prasad, R
Chandra, J
Koul, A
Smriti, M
Varma, A
Skurray, RA
Firth, N
Brown, MH
Koo, SP
Yeaman, MR
Citation: As. Bayer et al., In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membranefluidity, INFEC IMMUN, 68(6), 2000, pp. 3548-3553
Authors:
Yeaman, MR
Bayer, AS
Citation: Mr. Yeaman et As. Bayer, Antimicrobial peptides from platelets, DRUG RESIST, 2(2), 1999, pp. 116-126
Authors:
Xiong, YQ
Yeaman, MR
Bayer, AS
Citation: Yq. Xiong et al., In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action, ANTIM AG CH, 43(5), 1999, pp. 1111-1117
Authors:
Kupferwasser, LI
Skurray, RA
Brown, MH
Firth, N
Yeaman, MR
Bayer, AS
Citation: Li. Kupferwasser et al., Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: Role of the qacA locus, ANTIM AG CH, 43(10), 1999, pp. 2395-2399
Authors:
Dhawan, VK
Yeaman, MR
Bayer, AS
Citation: Vk. Dhawan et al., Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis, J INFEC DIS, 180(5), 1999, pp. 1561-1568
Authors:
Koo, SP
Bayer, AS
Kagan, BL
Yeaman, MR
Citation: Sp. Koo et al., Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude, INFEC IMMUN, 67(5), 1999, pp. 2475-2481
Authors:
Kupferwasser, LI
Yeaman, MR
Shapiro, SM
Nast, CC
Sullam, PM
Filler, SG
Bayer, AS
Citation: Li. Kupferwasser et al., Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects, CIRCULATION, 99(21), 1999, pp. 2791-2797
Authors:
Bayer, AS
Cheng, D
Yeaman, MR
Corey, GR
McClelland, RS
Harrel, LJ
Fowler, VG
Citation: As. Bayer et al., In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source, ANTIM AG CH, 42(12), 1998, pp. 3169-3172
Risultati:
1-14
|